|
Diabetes, Vol 48, Issue 2 426-429, Copyright © 1999 by American Diabetes Association
Leptin promotes aggregation of human platelets via the long form of its receptor
M Nakata, T Yada, N Soejima and I Maruyama
Department of Laboratory Medicine, Kagoshima University School of Medicine, Japan.
Plasma leptin levels are elevated in most obese individuals, and obesity is
accompanied by a high incidence of cardiovascular disease. Therefore,
leptin could be involved in the pathogenesis of cardiovascular disease. In
the present study, the role of leptin was explored in the regulation of
platelet function. The expression of the long form of the leptin receptor
was detected in human platelets. At 50 ng/ml, human leptin induced
phosphorylation of several proteins of platelets at the tyrosine residue.
Neither leptin at concentrations < or = 100 ng/ml nor ADP at
concentrations > or = 1 micromol/l affected platelet aggregation.
However, after pretreatment with 100 ng/ml leptin for 5 min, 1 micromol/l
ADP caused aggregation. Thus, leptin and ADP acted synergistically. At a
concentration of 2 micromol/l, ADP induced platelet aggregation, which was
markedly enhanced by 30-100 ng/ml leptin in a concentration-dependent
manner. This concentration range corresponds to that of plasma leptin
levels in obese individuals. At the lower concentrations (< 10 ng/ml)
that are observed in normal individuals, leptin had no effect on platelet
aggregation. In conclusion, leptin at high concentrations has the novel
function of promoting platelet aggregation, which may be a key coupling
factor between obesity and the cardiovascular disease associated with
syndrome X and diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Zeidan, S. Javadov, S. Chakrabarti, and M. Karmazyn
Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA/ROCK-dependent p38 MAPK translocation to nuclei
Cardiovasc Res,
October 24, 2007;
(2007)
cvm020v2.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Yang and L. A. Barouch
Leptin Signaling and Obesity: Cardiovascular Consequences
Circ. Res.,
September 14, 2007;
101(6):
545 - 559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zeidan, B. Paylor, K. J. Steinhoff, S. Javadov, V. Rajapurohitam, S. Chakrabarti, and M. Karmazyn
Actin Cytoskeleton Dynamics Promotes Leptin-Induced Vascular Smooth Muscle Hypertrophy via RhoA/ROCK- and Phosphatidylinositol 3-Kinase/Protein Kinase B-Dependent Pathways
J. Pharmacol. Exp. Ther.,
September 1, 2007;
322(3):
1110 - 1116.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fantuzzi and T. Mazzone
Adipose Tissue and Atherosclerosis: Exploring the Connection
Arterioscler. Thromb. Vasc. Biol.,
May 1, 2007;
27(5):
996 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Bodary, Y. Shen, M. Ohman, K. L. Bahrou, F. B. Vargas, S. S. Cudney, K. J. Wickenheiser, M. G. Myers Jr, and D. T. Eitzman
Leptin Regulates Neointima Formation After Arterial Injury Through Mechanisms Independent of Blood Pressure and the Leptin Receptor/STAT3 Signaling Pathways Involved in Energy Balance
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2007;
27(1):
70 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Mertens, R. V Considine, M. Van der Planken, and L. F Van Gaal
Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?
Eur. J. Endocrinol.,
September 1, 2006;
155(3):
477 - 484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Canavan, R. O. Salem, S. Schurgin, P. Koutkia, I. Lipinska, M. Laposata, and S. Grinspoon
Effects of Physiological Leptin Administration on Markers of Inflammation, Platelet Activation, and Platelet Aggregation during Caloric Deprivation
J. Clin. Endocrinol. Metab.,
October 1, 2005;
90(10):
5779 - 5785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. S. Elbatarny and D. H. Maurice
Leptin-mediated activation of human platelets: involvement of a leptin receptor and phosphodiesterase 3A-containing cellular signaling complex
Am J Physiol Endocrinol Metab,
October 1, 2005;
289(4):
E695 - E702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Bodary, S. Gu, Y. Shen, A. H. Hasty, J. M. Buckler, and D. T. Eitzman
Recombinant Leptin Promotes Atherosclerosis and Thrombosis in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol.,
August 1, 2005;
25(8):
e119 - e122.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Li, J.-C. Mamputu, N. Wiernsperger, and G. Renier
Signaling Pathways Involved in Human Vascular Smooth Muscle Cell Proliferation and Matrix Metalloproteinase-2 Expression Induced by Leptin: Inhibitory Effect of Metformin
Diabetes,
July 1, 2005;
54(7):
2227 - 2234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Dandona, A. Aljada, A. Chaudhuri, P. Mohanty, and R. Garg
Metabolic Syndrome: A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation
Circulation,
March 22, 2005;
111(11):
1448 - 1454.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Ekmekci, O. B. Ekmekci, H. Sonmez, Z. Ozturk, N. Domanic, and E. Kokoglu
Evaluation of Fibronectin, Vitronectin, and Leptin Levels in Coronary Artery Disease: Impacts on Thrombosis and Thrombolysis
Clinical and Applied Thrombosis/Hemostasis,
January 1, 2005;
11(1):
63 - 70.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Konstantinides, K. Schafer, J. G. Neels, C. Dellas, and D. J. Loskutoff
Inhibition of Endogenous Leptin Protects Mice From Arterial and Venous Thrombosis
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2004;
24(11):
2196 - 2201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Suganami, H. Takagi, H. Ohashi, K. Suzuma, I. Suzuma, H. Oh, D. Watanabe, T. Ojima, T. Suganami, Y. Fujio, et al.
Leptin Stimulates Ischemia-Induced Retinal Neovascularization: Possible Role of Vascular Endothelial Growth Factor Expressed in Retinal Endothelial Cells
Diabetes,
September 1, 2004;
53(9):
2443 - 2448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Park, Y. Liu-Stratton, L. C. Medeiros, S. A. Mccune, and M. J. Radin
Effect of Male Sex and Obesity on Platelet Arachidonic Acid in Spontaneous Hypertensive Heart Failure Rats
Experimental Biology and Medicine,
July 1, 2004;
229(7):
657 - 664.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Chua Jr., S. M. Liu, Q. Li, A. Sun, W. F. DeNino, S. B. Heymsfield, and X. E. Guo
Transgenic complementation of leptin receptor deficiency. II. Increased leptin receptor transgene dose effects on obesity/diabetes and fertility/lactation in lepr-db/db mice
Am J Physiol Endocrinol Metab,
March 1, 2004;
286(3):
E384 - E392.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. Schafer, M. Halle, C. Goeschen, C. Dellas, M. Pynn, D. J. Loskutoff, and S. Konstantinides
Leptin Promotes Vascular Remodeling and Neointimal Growth in Mice
Arterioscler. Thromb. Vasc. Biol.,
January 1, 2004;
24(1):
112 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Stephenson, J. Tunstead, A. Tsai, R. Gordon, S. Henderson, and H. M. Dansky
Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db Mice
Arterioscler. Thromb. Vasc. Biol.,
November 1, 2003;
23(11):
2027 - 2033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Maingrette and G. Renier
Leptin Increases Lipoprotein Lipase Secretion by Macrophages: Involvement of Oxidative Stress and Protein Kinase C
Diabetes,
August 1, 2003;
52(8):
2121 - 2128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.A Glader, L.S Birgander, S Soderberg, H.P Ildgruben, P Saikku, A Waldenstrom, and G.H Dahlen
Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis
Eur. Heart J.,
January 2, 2003;
24(2):
198 - 208.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Corica, A. Corsonello, F. Perticone, P. F. Bodary, and D. T. Eitzman
Effects of Leptin on Platelet Function in Obese Patients
JAMA,
July 17, 2002;
288(3):
313 - 314.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Mark and W. I. Sivitz
Uncoupling Metabolism and Coupling Leptin to Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2002;
22(6):
881 - 883.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Bodary, R. J. Westrick, K. J. Wickenheiser, Y. Shen, and D. T. Eitzman
Effect of Leptin on Arterial Thrombosis Following Vascular Injury in Mice
JAMA,
April 3, 2002;
287(13):
1706 - 1709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Glasow, W. Kiess, U. Anderegg, A. Berthold, A. Bottner, and J. Kratzsch
Expression of Leptin (Ob) and Leptin Receptor (Ob-R) in Human Fibroblasts: Regulation of Leptin Secretion by Insulin
J. Clin. Endocrinol. Metab.,
September 1, 2001;
86(9):
4472 - 4479.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J L Durstine, R W Thompson, K L Drowatzky, and W P Bartoli
Leptin and exercise: new directions
Br. J. Sports Med.,
February 1, 2001;
35(1):
3 - 4.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Fantuzzi and R. Faggioni
Leptin in the regulation of immunity, inflammation, and hematopoiesis
J. Leukoc. Biol.,
October 1, 2000;
68(4):
437 - 446.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Diabetes Association.
|
|
| |
|